Variable Clinical Courses of Varicella Zoster Virus Infection-related or Vaccination-related Bone Marrow Failure

J Pediatr Hematol Oncol. 2024 Jul 1;46(5):e354-e359. doi: 10.1097/MPH.0000000000002866. Epub 2024 Apr 23.

Abstract

We report 5 children with bone marrow failure (BMF) after primary varicella zoster virus (VZV) infection or VZV vaccination, highlighting the highly variable course. Two patients were treated with intravenous immunoglobulins; one had a slow hematologic recovery, and the other was rescued by allogeneic hematopoietic stem cell transplantation (HSCT). Of the 2 patients treated with immunosuppressive therapy with antithymocyte globulin and cyclosporine, one had a complete response, and the other was transplanted for nonresponse. One patient underwent a primary allograft. All patients are alive. This study demonstrated that VZV-associated BMF is a life-threatening disorder that often requires HSCT.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Bone Marrow Diseases / etiology
  • Bone Marrow Failure Disorders / etiology
  • Chickenpox Vaccine / adverse effects
  • Child
  • Child, Preschool
  • Female
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Herpesvirus 3, Human
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant
  • Male
  • Vaccination / adverse effects
  • Varicella Zoster Virus Infection*

Substances

  • Chickenpox Vaccine
  • Immunoglobulins, Intravenous